Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1991 Apr;44(4):341–342. doi: 10.1136/jcp.44.4.341

Persistent polyclonal B lymphocytosis with Epstein-Barr virus antibodies and subsequent malignant pulmonary blastoma.

E Lawlor 1, M Murray 1, D S O'Briain 1, C Blaney 1, L Foroni 1, P Sarsfield 1, D Condell 1, F Sullivan 1, S R McCann 1
PMCID: PMC496916  PMID: 1851502

Abstract

Persistent polyclonal B lymphocytosis (PPBL), a rare benign lymphoproliferative disorder, occurred in a 25 year old woman. The lymphocytes showed the phenotype cIgM+, FMC7+, CD19+, CD20+, which was similar to that seen in Waldenstrom's macroglobinaemia, but the proliferation was repeatedly shown to be polyclonal both immunologically and by immunoglobulin gene rearrangement studies. Eleven years after presentation the patient developed a malignant pulmonary blastoma, a rare pulmonary tumour of combined epithelial and mesenchymal origin. The failure to develop a lymphoid malignancy over 11 years together with immunological and genetic evidence of polyclonality confirms that PPBL is a benign lymphoproliferative disorder. The subsequent occurrence of a nonhaemopoietic malignancy suggests that benign lymphoid proliferations, like their malignant counterparts, may predispose to the development of neoplasia. A role for Epstein-Barr virus in the pathogenesis of one or both of these rare conditions is suggested by the finding of raised Epstein-Barr viral capsid antigen titres.

Full text

PDF
341

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allday M. J., Crawford D. H. Role of epithelium in EBV persistence and pathogenesis of B-cell tumours. Lancet. 1988 Apr 16;1(8590):855–857. doi: 10.1016/s0140-6736(88)91604-2. [DOI] [PubMed] [Google Scholar]
  2. Fung C. H., Lo J. W., Yonan T. N., Milloy F. J., Hakami M. M., Changus G. W. Pulmonary blastoma: an ultrastructural study with a brief review of literature and a discussion of pathogenesis. Cancer. 1977 Jan;39(1):153–163. doi: 10.1002/1097-0142(197701)39:1<153::aid-cncr2820390126>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  3. Gordon D. S., Jones B. M., Browning S. W., Spira T. J., Lawrence D. N. Persistent polyclonal lymphocytosis of B lymphocytes. N Engl J Med. 1982 Jul 22;307(4):232–236. doi: 10.1056/NEJM198207223070407. [DOI] [PubMed] [Google Scholar]
  4. Kucharska-Pulczynska M., Ellegaard J., Hokland P. Analysis of leucocyte differentiation antigens in blood and bone marrow from patients with Waldenström's macroglobulinaemia. Br J Haematol. 1987 Apr;65(4):395–399. doi: 10.1111/j.1365-2141.1987.tb04139.x. [DOI] [PubMed] [Google Scholar]
  5. Spring S. B., Schluederberg A., Allen W. P., Gruber J. Pathogenic diversity of Epstein-Barr virus. J Natl Cancer Inst. 1989 Jan 4;81(1):13–20. doi: 10.1093/jnci/81.1.13. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES